The Vacuolar H+-ATPase B1 Subunit Polymorphism p.E161K Associates with Impaired Urinary Acidification in Recurrent Stone Formers
Nasser A. Dhayat(University of Bern), Daniel G. Fuster(University of Bern), André Schaller(University of Bern), Orson W. Moe(Io Therapeutics (United States)), Sabina Gallati(University Children’s Hospital Bern), John Poindexter, Bruno Vogt(Hypertension Institute), Giuseppe Albano(University of Palermo), Carolyn Griffith, Andreas Pasch(Johannes Kepler University of Linz)
Cited by 55
Related Papers
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
|The Lancet|2017|923
Recurrent Rearrangements of Chromosome 1q21.1 and Variable Pediatric Phenotypes
|New England Journal of Medicine|2008|811
Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney Foundation
|American Journal of Kidney Diseases|2018|644
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
|New England Journal of Medicine|2021|509
Renal Transport of Uric Acid: Evolving Concepts and Uncertainties
|Advances in Chronic Kidney Disease|2012|394